A large, Swedish pharmacoepidemiological study has found that the risk of acute pancreatitis is increased 60% in current tetracycline users (that is, those to whom the drug was dispensed 0–30 days before the pancreatitis index date). Previous tetracycline use of any kind (defined as recent, past or former) was not associated with an increased odds ratio for acute pancreatitis.